You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 4, April 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Leber's Hereditary Optic Neuropathy

Clinical Manifestations of the 14484 Mutation

Donald R. Johns, MD; Katrinka L. Heher, MD; Neil R. Miller, MD; Kyle H. Smith, MD

Arch Ophthalmol. 1993;111(4):495-498.


Abstract

• Objective.
—To define the clinical features of Leber's hereditary optic neuropathy associated with the 14484 mitochondrial DNA mutation and to compare these features with those associated with three other pathogenetic mutations.

Design and Patients.
—Clinical and historical data were collected from 19 visually symptomatic patients from 17 independent pedigrees with the molecularly confirmed 14484 mutation.

Main Outcome Measures.
—Demographic features, age of onset of visual loss, nadir of visual acuity, occurrence and timing of visual recovery, family history of visual loss, and associated medical and environmental conditions.

Results.
—Clinical characteristics associated with the 14484 mutation are similar overall to those of the three other primary mutations. One notable distinguishing feature is the higher incidence of visual recovery among patients with the 14484 mutation. Thirty-seven percent of our patients experienced visual recovery compared with 5% with the 11778 mutation (P<.001), 22% with the 3460 mutation, and 29% with the 15257 mutation. The average age of onset of visual symptoms for the patients with the 14484 mutation who had visual recovery was younger than for those without recovery (19.6 vs 30.6 years). Thirteen of the 19 patients had a history of metabolic disturbance, trauma, or substance abuse.

Conclusions.
—Leber's hereditary optic neuropathy associated with the 14484 mitochondrial DNA mutation may have a better prognosis for visual recovery. The phenotypic expression of the 14484 mutation may be influenced by concurrent medical and environmental factors. Molecular genetic testing in suspected Leber's hereditary optic neuropathy is useful to confirm the diagnosis and to assess visual prognosis.



Author Affiliations

From the Departments of Neurology (Drs Johns and Miller) and Ophthalmology, Wilmer Eye Institute (Drs Heher and Miller), The Johns Hopkins University School of Medicine, Baltimore, Md; and the Department of Ophthalmology, Scott and White Clinic, Temple, Tex (Dr Smith).


Footnotes

Accepted for publication January 11, 1992.

Reprint requests to Department of Neurology, The Johns Hopkins Hospital, Meyer 6-119, 600 N Wolfe St, Baltimore, MD 21287-7619 (Dr Johns).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases
Rahman and Hanna
J. Neurol. Neurosurg. Psychiatry 2009;80:943-953.
ABSTRACT | FULL TEXT  

Inherited mitochondrial optic neuropathies
Yu-Wai-Man et al.
J. Med. Genet. 2009;46:145-158.
ABSTRACT | FULL TEXT  

Leber's Hereditary Optic Neuropathy with Childhood Onset
Barboni et al.
IOVS 2006;47:5303-5309.
ABSTRACT | FULL TEXT  

Mitochondrial DNA haplogroup distribution within Leber hereditary optic neuropathy pedigrees
Man et al.
J. Med. Genet. 2004;41:e41-e41.
FULL TEXT  

Leber hereditary optic neuropathy
Man et al.
J. Med. Genet. 2002;39:162-169.
ABSTRACT | FULL TEXT  

`Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation
Lodi et al.
Brain 2000;123:1896-1902.
ABSTRACT | FULL TEXT  

Leber's hereditary optic neuropathy and maturity onset diabetes mellitus: is there a metabolic association?
COLE and DUTTON
Br J Ophthalmol 2000;84:439a-439.
FULL TEXT  

Mitochondrial DNA analysis: polymorphisms and pathogenicity
Chinnery et al.
J. Med. Genet. 1999;36:505-510.
ABSTRACT | FULL TEXT  

Identical Twins No Longer Discordant for Leber's Hereditary Optic Neuropathy
Lam
Arch Ophthalmol 1998;116:956-957.
FULL TEXT  

Normal Respiratory Chain Function in Patients With Low-tension Glaucoma
Brierley et al.
Arch Ophthalmol 1996;114:142-146.
ABSTRACT  

Leber's Hereditary Optic Neuropathy Masquerading as Tobacco-Alcohol Amblyopia
Cullom et al.
Arch Ophthalmol 1993;111:1482-1485.
ABSTRACT  

Identical Twins Who Are Discordant for Leber's Hereditary Optic Neuropathy
Johns et al.
Arch Ophthalmol 1993;111:1491-1494.
ABSTRACT  

A Maculopathy Associated With the 15257 Mitochondrial DNA Mutation
Heher and Johns
Arch Ophthalmol 1993;111:1495-1499.
ABSTRACT  

Functional Analysis of Lymphoblast and Cybrid Mitochondria Containing the 3460, 11778, or 14484 Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutation
Brown et al.
J. Biol. Chem. 2000;275:39831-39836.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.